Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2
Published October 17, 2018 · Recall initiated: September 20, 2018
Summary
FDA records drug Class II recall D-0010-2019, published October 17, 2018 and initiated September 20, 2018. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 7777 bottles; Lot: Lot: T71137 Exp. Feb. 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations; rejected product was used to manufacture final bulk lot
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pfizer Inc.
- Distributor
- Nationwide
- Lot
- Lot: T71137 Exp. Feb. 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only,August 6, 2025
- FDABicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only,August 6, 2025
- FDADOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials,July 2, 2025
- FDALabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile CartridgeJuly 3, 2024
- FDAThyroid powder, 4.5 kg foil bag, 5x1 kg foil bags packed in 25 Kg Fiber Drum, Thyroid Powder 25kg/drum, USOctober 17, 2018
- FDAPantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: JubilantOctober 17, 2018
Questions about this recall
Was Glipizide XL (glipizide) extended-release tablets 5 mg 500-tablet bottle, Rx only Distributed by: Greenstone LLC. Peapack, NJ 07977 --- NDC 59762-0541-2 recalled?
Yes. FDA published recall D-0010-2019 on October 17, 2018. Reported hazard: CGMP Deviations; rejected product was used to manufacture final bulk lot
What should I do if I have this product?
Voluntary: Firm initiated · Letter